An important realization was that it’s not the primary tumor that often claims lives — it’s the spread of cancer to other ...

"The findings uncover a new way in which the immune system is suppressed, limiting T cells from fighting cancer spread. This ...

"It was a ‘eureka’ moment when we found TXA2 was the molecular signal that ... "This new study further demonstrates how aspirin and other inhibitors of this pathway could be used in new ...

As researchers explain in a release from the University of Cambridge, aspirin can reduce a clotting factor known as thromboxane A2 (TXA2). But a side effect of this clotting factor is that it ...

The study, published in Nature, found that, in mice, aspirin acted on platelets — the tiny cells that cause blood to clot — making them produce less of a clotting factor, thromboxane A2 (TXA2 ...

They found that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2) – this was an unexpected finding for the scientists. TXA2 is produced by ...

troyanphoto – stock.adobe.com Aspirin can help the immune system fight cancer spread by blocking a chemical (TXA2), made by blood platelets, that would otherwise weaken the body’s T cells ...

The team found that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2). TXA2 is produced by platelets in the blood and aspirin is already known to ...